172@29@17@151!~!172@29@0@53!~!|news|tags|astrazeneca.html!~!|controller|tag.php
you are here: HomeNewsAstrazeneca
astrazeneca
Jump to
94 Results Found
  • Won't profit from COVID-19 vaccine in pandemic: AstraZeneca Jul 31, 2020 07:37 AM IST

    Won't profit from COVID-19 vaccine in pandemic: AstraZeneca

    AstraZeneca has struck a number of deals around the world to supply the experimental COVID-19 vaccine, which has shown promise in early testing.

  • Britain's AstraZeneca tops estimates as coronavirus vaccine hopes persist Jul 30, 2020 03:00 PM IST

    Britain's AstraZeneca tops estimates as coronavirus vaccine hopes persist

    The company reiterated that it was on track with late-stage trials for its coronavirus vaccine, which could be rolled out by the year-end.

  • Emergent BioSolutions signs $174 million deal to make AstraZeneca's potential COVID-19 vaccine Jul 27, 2020 05:41 PM IST

    Emergent BioSolutions signs $174 million deal to make AstraZeneca's potential COVID-19 vaccine

    AstraZeneca in June picked Emergent to help produce 300 million doses of its potential COVID-19 vaccine pledged to the United States.

  • AstraZeneca bets up to $6 billion on new Daiichi cancer drug Jul 27, 2020 02:15 PM IST

    AstraZeneca bets up to $6 billion on new Daiichi cancer drug

    London-listed AstraZeneca said on Monday it would make an upfront payment of $1 billion to Daiichi for an experimental drug called DS-1062, which belongs to a newer class of treatments called antibody drug conjugates (ADC).

  • Coronavirus vaccine update | Here are 3 most promising candidates in final stages of trial Jul 25, 2020 07:57 PM IST

    Coronavirus vaccine update | Here are 3 most promising candidates in final stages of trial

    With over 1.5 crore people across the globe having contracted the infection, the world is eagerly awaiting a vaccine that would bolster the global fight against COVID-19.

  • Explained | Why AstraZeneca-Oxford vaccine offers hope Jul 21, 2020 08:54 PM IST

    Explained | Why AstraZeneca-Oxford vaccine offers hope

    In this edition of the Explained series, find out what it means for the fight against COVID-19.

  • Over a million doses of Oxford/AstraZeneca COVID-19 vaccine possible by September: Researcher Jul 20, 2020 10:24 PM IST

    Over a million doses of Oxford/AstraZeneca COVID-19 vaccine possible by September: Researcher

    'There might be a million doses manufactured by September: that now seems like a remarkable underestimate, given the scale of what's going on,' Adrian Hill of University of Oxford said, referring to the manufacturing capability of partner AstraZeneca.

  • First human trial of Oxford-AstraZeneca COVID-19 vaccine shows promise, produces immune response Jul 20, 2020 07:37 PM IST

    First human trial of Oxford-AstraZeneca COVID-19 vaccine shows promise, produces immune response

    The vaccine did not prompt any serious side effects and elicited antibody and T-cell immune responses

  • First human trial of AstraZeneca COVID-19 vaccine shows promise Jul 20, 2020 07:29 PM IST

    First human trial of AstraZeneca COVID-19 vaccine shows promise

    The vaccine called AZD1222 and under development by AstraZeneca and scientists at Britain's Oxford University, did not prompt any serious side effects and elicited antibody and T-cell immune responses, according to trial results published in The Lancet medical journal.

  • COVID-19: Vaccine alliance says 75 countries keen to join "COVAX" access facility Jul 15, 2020 09:16 PM IST

    COVID-19: Vaccine alliance says 75 countries keen to join "COVAX" access facility

    COVAX is co-led by GAVI, the World Health Organization and the CEPI Coalition for Epidemic Preparedness Innovations. Its aim is to deliver 2 billion doses of effective, approved COVID-19 vaccines by the end of 2021.

  • Positive news on Oxford University/AstraZeneca COVID-19 vaccine could come on Thursday: Report Jul 15, 2020 05:43 PM IST

    Positive news on Oxford University/AstraZeneca COVID-19 vaccine could come on Thursday: Report

    The developers of the vaccine said this month they are encouraged by the immune response they have seen in trials so far and were expecting to be able to publish Phase 1 data by the end of July.

  • AstraZeneca says Brazil close to coronavirus vaccine deal Jun 30, 2020 08:16 AM IST

    AstraZeneca says Brazil close to coronavirus vaccine deal

    AstraZeneca director Jorge Mazzei told reporters on Monday that if the vaccine works he believes the hard-hit South American nation will get it at the end of the year. But he has just had the first call with local partners Fiocruz and will start working on a contract on Tuesday.

  • WHO chief scientist says Astrazeneca, Moderna most advanced in COVID-19 vaccine race Jun 26, 2020 07:35 PM IST

    WHO chief scientist says Astrazeneca, Moderna most advanced in COVID-19 vaccine race

    Soumya Swaminathan said that Moderna's COVID-19 vaccine candidate was ‘not far behind’ Astrazeneca's, among more than 200 candidates, 15 of which have entered clinical trials

  • Pig trial of AstraZeneca's COVID-19 vaccine shows promise with two shots Jun 23, 2020 04:25 PM IST

    Pig trial of AstraZeneca's COVID-19 vaccine shows promise with two shots

    The ChAdOx1 nCoV-19 vaccine, also known as AZD1222, was originally developed by Oxford University scientists, who are now working with AstraZeneca on development and production.

  • AstraZeneca COVID-19 vaccine likely to protect for a year: CEO Jun 16, 2020 01:50 PM IST

    AstraZeneca COVID-19 vaccine likely to protect for a year: CEO

    The British drugmaker has already begun human trials of the vaccine developed by the University of Oxford, with a phase I trial in Britain due to end soon and a phase III trial already begun, Pascal Soriot told broadcaster Bel RTL.

  • Italy, Germany, France and Netherlands sign contract with Astrazeneca for COVID-19 vaccine Jun 13, 2020 07:20 PM IST

    Italy, Germany, France and Netherlands sign contract with Astrazeneca for COVID-19 vaccine

    The contract is for 400 million doses of the vaccine, which was developed with the University of Oxford and whose experimentation phase is already advanced and expected to end in autumn, Roberto Speranza said in a Facebook post.

  • AstraZeneca contacted Gilead over potential megamerger: Report Jun 08, 2020 09:20 AM IST

    AstraZeneca contacted Gilead over potential megamerger: Report

    Such a deal would unite two of the drugmakers at the forefront of the industry's efforts to fight the new coronavirus and could be politically sensitive as governments seek control over potential vaccines or treatments.

  • AstraZeneca joins Serum Institute to supply 2 billion doses of coronavirus vaccine Jun 04, 2020 10:53 PM IST

    AstraZeneca joins Serum Institute to supply 2 billion doses of coronavirus vaccine

    AstraZeneca has agreed terms with Serum Institute of India to supply one billion doses for low and middle-income countries

  • AstraZeneca aims at two billion doses with new COVID-19 vaccine deals Jun 04, 2020 09:55 PM IST

    AstraZeneca aims at two billion doses with new COVID-19 vaccine deals

    AstraZeneca's partnership with Oxford University has garnered international attention as one of the leading coronavirus vaccine candidates, sealing more than $1 billion in U.S. government funding last month as it ramps up testing of the vaccine and manufacturing capacity.

  • US secures 300 million doses of potential AstraZeneca COVID-19 vaccine May 22, 2020 07:22 AM IST

    US secures 300 million doses of potential AstraZeneca COVID-19 vaccine

    While not yet proven to be effective against the coronavirus, vaccines are seen by world leaders as the only real way to restart their stalled economies, and even to get an edge over global competitors.

  • US secures 300 million doses of potential AstraZeneca COVID-19 vaccine May 21, 2020 05:33 PM IST

    US secures 300 million doses of potential AstraZeneca COVID-19 vaccine

    While not proven to be effective against the coronavirus, vaccines are seen by many world leaders as the only real way to restart their stalled economies, and even to get an edge over global competitors.

  • Coronavirus pandemic | Data from COVID-19 vaccine's phase-1 trials to be out in a month: AstraZeneca May 14, 2020 09:06 AM IST

    Coronavirus pandemic | Data from COVID-19 vaccine's phase-1 trials to be out in a month: AstraZeneca

    Pharmaceutical and biopharmaceutical company AstraZeneca is expected to start working manufacturing capabilities once the late stage of the COVID-19 vaccine's trials begin.

  • AstraZeneca's lung cancer treatment gets FDA nod Mar 30, 2020 01:47 PM IST

    AstraZeneca's lung cancer treatment gets FDA nod

    The combo treatment has been approved in the United States for adult patients with extensive-stage small cell lung cancer, the company said.

  • AstraZeneca, Merck score win with Lynparza approval for pancreatic cancer Dec 30, 2019 05:00 PM IST

    AstraZeneca, Merck score win with Lynparza approval for pancreatic cancer

    The drug is now the only approved medicine in biomarker-selected patients with advanced pancreatic cancer.

  • Sun Pharma inks licensing pact with AstraZeneca to introduce products in China Nov 06, 2019 10:00 AM IST

    Sun Pharma inks licensing pact with AstraZeneca to introduce products in China

    This comes after AstraZeneca said it was launching a new fund with China International Capital Corp to invest $1 billion in China's healthcare sector, as it expands its research work in the country.

Sections